Diabetes
Conference Coverage
‘Striking’ benefit of lipid lowering in primary prevention
“If patients can’t tolerate a statin, then treat them with bempedoic acid. The bottom line is that these patients just need to be treated.”
Conference Coverage
SURMOUNT-2: Tirzepatide rings up major weight loss in type 2 diabetes
Taken together, results from SURMOUNT-1 and SURMOUNT-2 appear to make a good case for a weight-loss indication that will not depend on whether a...
Latest News
Low copays drive better adherence to new diabetes drugs
Regardless of patients’ socioeconmic status, copays were related to adherence.
Latest News
NAFLD increases risk for severe infections
Physicians should assess their patients’ vaccination status and seek to control modifiable risk factors, such as diabetes.
Conference Coverage
A ‘one-stop shop’: New guidance on hormones and aging
Part of what we need to do is [provide] the evidence that we have, which includes evidence of when not to prescribe as well as [when] to prescribe...
From the Journals
Depression drives metabolic syndrome
The association between baseline depression and development of metabolic syndrome was strongest for those with severe depression.
Latest News
Could semaglutide treat addiction as well as obesity?
“I would say, overall, the jury is still out,” as to whether anecdotal reports of GLP-1 agonists curbing addictions will be borne out in...
From the Journals
Low-carb breakfast key to lower glucose variability in T2D?
“By making a small adjustment to the carb content of a single meal rather than the entire diet, we have the potential to increase adherence...
Latest News
Medicaid patients with heart failure get poor follow-up after hospital discharge
Both structural racism and problems with access are likely behind the low rates of follow-up care.
Feature
Continuous glucose monitors come to hospitals
CGM placement is essentially painless and requires less labor on the ward to manage.
News from the FDA/CDC
FDA warns people to avoid compounded semaglutide medicines
“Patients should be aware that some products sold as ‘semaglutide’ may not contain the same active ingredient as FDA-approved semaglutide products...